Whitfield Bryson & Mason
is making news.

WBM Probes Use of Drugs for ‘Low T’

Pharmaceutical companies are bombarding the media with advertising messages that any man with “Low T” has a disease that needs fixing by prescription medication. From 2001 to 2011, use of testosterone by men over 40 nearly quadrupled, with doctors prescribing it to men with normal levels who merely wished to increase their sex drive and just generally feel better than they normally feel.

 

Testosterone, however, is not without risks. A recent study found that in men over 65, and younger men with a history of cardiovascular disease, the risk of heart attacks doubled within three months of beginning testosterone therapy.

 

Testosterone, a naturally occurring hormone, appears to decline in men as a part of the aging process. Other factors may contribute to the decline as well: belly fat, other prescriptive drugs, as well as chronic diseases such as Type 2 diabetes. According to the Journal of Clinical Endocrinology and Metabolism, over the past few decades men’s average testosterone levels appear to be dropping about 1 percent per year.

 

For some men, clinical testosterone deficiency, or hypogonadism, is a medical diagnosis that is based on a measurement of the levels of testosterone in the blood, and can lead to a decline or outright loss of sex drive and fertility, bones that are more brittle, and symptoms similar to those of menopausal women. Prescriptive testosterone therapy can legitimately help men with this condition.

 

“Pharmaceutical companies, however, are sending that message that this therapy is good for any man who is simply looking to put a little pep in his step,” said Robert B. Brown III, a WBM partner, who is investigating these cases. “That’s not the case, and men need to carefully consider the risks. In addition, pharmaceutical companies must be held accountable for the way they market these drugs.”

 

If you or a loved one has been on testosterone therapy and has suffered a heart attack or other cardiovascular event, we can help. Our team has been investigating these cases and is leading the fight against big pharmaceutical companies that put profits ahead of safety. For a free consultation regarding your rights, contact us at 786.408.3249 or lowT@wbmllp.com.